Nuclear Medicine: Page 41

ARTMS, Isotopia produce PSMA-11 in cyclotron

By AuntMinnie.com staff writers

ARTMS and Isotopia Molecular Imaging have announced the multicurie labeling of a prostate-specific membrane antigen (PSMA)-11-based radiopharmaceutical using cyclotrons.

January 19, 2021

Blue Earth eyes new uses for fluciclovine F-18

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics announced that the first patient has been dosed in a phase III clinical study examining the use of its Axumin (fluciclovine fluorine-18, F-18) PET radiopharmaceutical for detecting recurrent brain metastases.

January 14, 2021

Report charts 80% drop in cardiac SPECT during COVID-19

By Emily Hayes

A hospital in Alabama saw an 80% drop in the volume of SPECT myocardial perfusion imaging studies during the peak of the COVID-19 pandemic in spring 2020 as patients postponed nonessential procedures.

January 14, 2021

Actinium, Astellas to create actinium-225 radiotherapies

By AuntMinnie.com staff writers

Immunotherapy technology developer Actinium Pharmaceuticals will work with Astellas Pharma to develop new actinium-225 targeted radiotherapies.

January 12, 2021

Lantheus submits drug master file for imaging biomarker

By AuntMinnie.com staff writers

Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it has filed a drug master file with the U.S. Food and Drug Administration for NM-01, a PD-L1 imaging biomarker for use in nuclear medicine.

January 11, 2021

ARTMS, Telix produce PSMA-11 in cyclotron

By AuntMinnie.com staff writers

ARTMS and Telix Pharmaceuticals this week announced a milestone in their relationship to produce a prostate-specific membrane antigen (PSMA)-11-based radiopharmaceutical using cyclotrons.

January 11, 2021

Could AI lower malpractice risk for physicians?

By Erik L. Ridley

Although some legal scholars believe that liability concerns could hinder adoption of artificial intelligence (AI) software in personalized medicine, a new study published in the Journal of Nuclear Medicine found that physicians who follow the technology's advice may actually be shielded from malpractice liability.

January 11, 2021

Avacta inks license agreement with Point Biopharma

By AuntMinnie.com staff writers

Avacta Group has signed a license agreement with Point Biopharma to provide that company with access to its pre/Cision technology for developing tumor-activated radiopharmaceuticals.

January 6, 2021

NorthStar gets FDA nod to produce Mo-99 from cMo-98

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has received U.S. Food and Drug Administration (FDA) approval to produce molybdenum-99 (Mo-99) from concentrated molybdenum-98 (cMo-98).

January 5, 2021

Report: COVID-19 causing radioisotope delays

By AuntMinnie.com staff writers

A drop in the volume of passenger airline travel is causing delays in the shipment of medical radioisotopes from sources in Canada, according to a January 3 report by Reuters.

January 3, 2021

ARTMS Tc-99m gets green light from Health Canada

By AuntMinnie.com staff writers

Medical isotope developer ARTMS of British Columbia, Canada, announced that its cyclotron-produced technetium-99m (Tc-99m) radioisotope is being shipped commercially following approval on November 26 for clinical use by Health Canada.

December 21, 2020

SNMMI: Imagers should get COVID-19 shots early

By AuntMinnie.com staff writers

Imaging professionals should be considered among the healthcare personnel prioritized for receiving COVID-19 vaccinations, according to the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

December 16, 2020

Previous Page

Page 41 of 440

Next Page